| Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer (NCT00005807) | Albert Einstein College of Medicine | 2000-07-01 |
| Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors (NCT00006018) | Case Comprehensive Cancer Center | 2000-07-01 |
| BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer (NCT00006086) | H. Lee Moffitt Cancer Center and Research Institute | 2000-06-01 |
| Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors (NCT00006088) | H. Lee Moffitt Cancer Center and Research Institute | 2000-06-01 |
| Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide (NCT00006047) | H. Lee Moffitt Cancer Center and Research Institute | 2000-06-01 |
| CP-609,754 in Treating Patients With Advanced Solid Tumors (NCT00006085) | H. Lee Moffitt Cancer Center and Research Institute | 2000-06-01 |
| LY293111 in Treating Patients With Advanced Solid Tumors (NCT00006375) | Memorial Sloan Kettering Cancer Center | 2000-06-01 |
| VNP20009 in Treating Patients With Advanced Solid Tumors (NCT00006254) | Vion Pharmaceuticals | 2000-05-01 |
| SU5416 in Treating Patients With Advanced Solid Tumors (NCT00005642) | Case Comprehensive Cancer Center | 2000-05-01 |
| Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain (NCT00020605) | Dana-Farber Cancer Institute | 2000-05-01 |
| Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer (NCT00004144) | Barbara Ann Karmanos Cancer Institute | 2000-05-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00005819) | Case Comprehensive Cancer Center | 2000-04-01 |
| Vaccine Therapy in Treating Patients With Advanced Cancer (NCT00004881) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases (NCT00006255) | Case Comprehensive Cancer Center | 2000-04-01 |
| BMS-214662 in Treating Patients With Solid Tumors (NCT00005973) | National Cancer Institute (NCI) | 2000-04-01 |
| Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter (NCT00006083) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00006036) | NCIC Clinical Trials Group | 2000-03-22 |
| Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment (NCT00005639) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-03-01 |
| Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors (NCT00005604) | National Cancer Institute (NCI) | 2000-03-01 |
| Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor (NCT00004243) | City of Hope Medical Center | 2000-03-01 |
| Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors (NCT00005078) | City of Hope Medical Center | 2000-03-01 |
| Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer (NCT00017537) | University of Alabama at Birmingham | 2000-03-01 |
| Endostatin in Treating Patients With Advanced Refractory Solid Tumors (NCT00004872) | University of Wisconsin, Madison | 2000-03-01 |
| Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer (NCT00020644) | Advocate Lutheran General Hospital | 2000-03-01 |
| Perifosine in Treating Patients With Advanced Solid Tumors (NCT00005794) | University of Wisconsin, Madison | 2000-02-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00006372) | Case Comprehensive Cancer Center | 2000-02-01 |
| Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00005068) | Mayo Clinic | 2000-01-01 |
| Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (NCT00005634) | Memorial Sloan Kettering Cancer Center | 2000-01-01 |
| Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue (NCT00004914) | Northwestern University | 2000-01-01 |
| Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss (NCT00004912) | Northwestern University | 2000-01-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00004913) | Northwestern University | 2000-01-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00009815) | University of Pittsburgh | 1999-12-01 |
| MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00004886) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-12-01 |
| St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer (NCT00005805) | Memorial Sloan Kettering Cancer Center | 1999-12-01 |
| Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors (NCT00005061) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-12-01 |
| Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors (NCT00009828) | University of Pittsburgh | 1999-12-01 |
| EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer (NCT00004258) | Indiana University | 1999-12-01 |
| PS-341 in Treating Patients With Advanced Cancer (NCT00006362) | Mayo Clinic | 1999-11-01 |
| Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593) | Fred Hutchinson Cancer Center | 1999-11-01 |
| Selenium in the Prevention of Cancer (NCT00022165) | University of Surrey | 1999-10-01 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (NCT00004241) | National Cancer Institute (NCI) | 1999-10-01 |
| ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy (NCT00004926) | Memorial Sloan Kettering Cancer Center | 1999-10-01 |
| Endostatin in Treating Patients With Advanced Solid Tumors (NCT00004229) | National Cancer Institute (NCI) | 1999-10-01 |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00005791) | Memorial Sloan Kettering Cancer Center | 1999-10-01 |
| Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer (NCT00004220) | City of Hope Medical Center | 1999-10-01 |
| Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00004242) | National Cancer Institute (NCI) | 1999-10-01 |
| Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer (NCT00004189) | National Cancer Institute (NCI) | 1999-10-01 |
| Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer (NCT00004173) | Ohio State University Comprehensive Cancer Center | 1999-10-01 |
| Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma (NCT00003993) | National Institute on Aging (NIA) | 1999-09-01 |
| VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy (NCT00004216) | Vion Pharmaceuticals | 1999-08-01 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery (NCT00004075) | Mayo Clinic | 1999-08-01 |
| Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer (NCT00004063) | The University of Texas Health Science Center, Houston | 1999-08-01 |
| Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma (NCT00005590) | Cancer Research Campaign Clinical Trials Centre | 1999-08-01 |
| Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00004079) | National Cancer Institute (NCI) | 1999-08-01 |
| GPX-100 in Treating Patients With Solid Tumors (NCT00003403) | Gem Pharmaceuticals | 1999-08-01 |
| Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer (NCT00019656) | National Cancer Institute (NCI) | 1999-08-01 |
| Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors (NCT00004090) | Northwestern University | 1999-08-01 |
| Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00004864) | Montefiore Medical Center | 1999-07-01 |
| Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors (NCT00004059) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (NCT00004927) | R-Pharm | 1999-07-01 |
| Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00004863) | Montefiore Medical Center | 1999-07-01 |
| PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00004002) | NYU Langone Health | 1999-07-01 |
| Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer (NCT00217724) | OHSU Knight Cancer Institute | 1999-07-01 |
| BMS-214662 in Treating Patients With Advanced Solid Tumors (NCT00004877) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| PNU 166148 in Treating Patients With Metastatic Solid Tumors (NCT00004076) | University of Glasgow | 1999-06-01 |
| Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00019708) | National Cancer Institute (NCI) | 1999-06-01 |
| Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors (NCT00004016) | University of Rochester | 1999-04-01 |
| SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00004049) | Genzyme, a Sanofi Company | 1999-04-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00003956) | Memorial Sloan Kettering Cancer Center | 1999-04-01 |
| Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors (NCT00004923) | Yale University | 1999-04-01 |
| CHS 828 in Treating Patients With Solid Tumors (NCT00003979) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-04-01 |
| Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant (NCT00003894) | Roswell Park Cancer Institute | 1999-03-01 |
| Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors (NCT00003882) | Roswell Park Cancer Institute | 1999-03-01 |
| Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors (NCT00003891) | NCIC Clinical Trials Group | 1999-02-25 |
| MG98 in Treating Patients With Advanced Solid Tumors (NCT00003890) | NCIC Clinical Trials Group | 1999-02-22 |
| Stereotactic Radiosurgery in Treating Patients With Liver Metastases, Lung Metastases, or Other Advanced Solid Tumors (NCT00006456) | Virginia Commonwealth University | 1999-02-01 |
| BIBX 1382 in Treating Patients With Solid Tumors (NCT00003980) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-02-01 |
| Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma (NCT00003970) | National Cancer Institute (NCI) | 1999-01-01 |
| Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00003899) | Fred Hutchinson Cancer Center | 1999-01-01 |
| Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas (NCT00004057) | Memorial Sloan Kettering Cancer Center | 1998-12-01 |
| Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy (NCT00003600) | Alliance for Clinical Trials in Oncology | 1998-12-01 |
| Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors (NCT00003690) | Mayo Clinic | 1998-12-01 |
| Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00003721) | The University of Texas Health Science Center at San Antonio | 1998-11-01 |
| Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer (NCT00003816) | Roswell Park Cancer Institute | 1998-10-19 |
| Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00003709) | The University of Texas Health Science Center at San Antonio | 1998-10-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00003707) | The University of Texas Health Science Center at San Antonio | 1998-10-01 |
| Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor (NCT00003755) | Memorial Sloan Kettering Cancer Center | 1998-10-01 |
| PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy (NCT00019565) | National Institutes of Health Clinical Center (CC) | 1998-10-01 |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00003742) | Memorial Sloan Kettering Cancer Center | 1998-10-01 |
| Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors (NCT00003768) | Case Comprehensive Cancer Center | 1998-09-01 |
| KRN7000 in Treating Patients With Solid Tumors (NCT00003985) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-09-01 |
| Docetaxel in Treating Patients With Solid Tumors (NCT00003565) | Alliance for Clinical Trials in Oncology | 1998-09-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00004105) | NYU Langone Health | 1998-09-01 |
| Geldanamycin Analogue in Treating Patients With Advanced Cancer (NCT00003969) | Cancer Research UK | 1998-08-01 |
| Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer (NCT00019604) | National Institutes of Health Clinical Center (CC) | 1998-08-01 |
| Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone (NCT00003884) | Novartis | 1998-08-01 |
| SR-45023A in Treating Patients With Advanced Solid Tumors (NCT00003822) | Genzyme, a Sanofi Company | 1998-08-01 |
| Irinotecan in Treating Patients With Advanced Solid Tumors (NCT00004051) | Memorial Sloan Kettering Cancer Center | 1998-08-01 |
| Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors (NCT00003710) | The University of Texas Health Science Center at San Antonio | 1998-08-01 |